A biotech company that has developed a 3D human lung model to replace animal testing
ImmuOne has raised €2.9M across 2 funding rounds from 5 investors, most recently a round in Mar 2025. Based in London, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-03-13 | Other | €716k | Mercia Ventures,Midlands Engine Investment Fund,Pioneer Group | View deal → |
| 2023-10-26 | Other | €2.2M | EIS funds,MEIF Proof of Concept & Early Stage Fund,Pioneer Group | View deal → |
